NCT06614426 is a NA clinical trial of Test group 1 (T1) in Peri Implantitis, sponsored by Abeer Hakam.

Who is sponsoring NCT06614426?

NCT06614426 is sponsored by Abeer Hakam.

What drugs are being tested in NCT06614426?

Interventions in NCT06614426: Test group 1 (T1), Test group 2 (T2), Control group (C).

What condition does NCT06614426 study?

NCT06614426 studies Peri Implantitis.

Is NCT06614426 still recruiting?

NCT06614426 is currently not yet recruiting. Last updated 26 September 2024.

Last reviewed 2024-09-26 · How we verify

NCT06614426

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Surgical Treatment of Peri-implantitis Defects

Not yet recruiting NA Last updated 26 September 2024

What this trial tests

NA trial testing Test group 1 (T1) in Peri Implantitis in 57 participants. Not yet recruiting.

Timeline

1 November 2024

Primary endpoint
30 November 2026

30 December 2026

Quick facts

Lead sponsor	Abeer Hakam
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	57
Start date	1 November 2024
Primary completion	30 November 2026
Estimated completion	30 December 2026

Drugs / interventions tested

Test group 1 (T1)
Test group 2 (T2)
Control group (C)

Conditions studied

Peri Implantitis — all drugs for Peri Implantitis →

Sponsor

Abeer Hakam

Who can join

18 and older, any sex, with Peri Implantitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the efficacy of implant surface decontamination using electrolysis cleaning system. And to evaluate the adjunctive use of L-PRF in promoting soft tissue healing and long-term stability of the peri-implant marginal bone in the surgical treatment of peri-implantitis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Peri Implantitis

Currently open trials in the same condition.

NCT07191522 — Efficacy of Photodynamic Therapy in the Non-Surgical Treatment of Peri-Implantitis · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06614426 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Abeer Hakam
Last refreshed: 26 September 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06614426.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing